Cencora, Inc. is a global pharmaceutical sourcing and distribution services company. The Company helps both healthcare providers and pharmaceutical and biotech manufacturers improve patient access to products and enhance patient care. The Company operates through two segments: U.S. Healthcare Solutions and International Healthcare Solutions. The U.S. Healthcare Solutions segment distributes a comprehensive offering of brand-name, specialty brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to a variety of healthcare providers, including acute care hospitals and health systems, independent and chain retail pharmacies, long-term care and alternate site pharmacies, and other customers. The International Healthcare Solutions segment consists of businesses that focus on international pharmaceutical wholesale and related service operations and global commercialization services.
Industry Leader
The company's revenue leads the industry, with the latest annual revenue totaling USD 321.33B.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 22.56% year-on-year.
High Dividend
The company is a high dividend payer, with the latest dividend payout ratio of 28.12%.
Stable Dividend
The company has regularly paid dividends over the past 5 years, with the latest dividend payout ratio of 28.12%.
Undervalued
The company’s latest PE is 20.68, at a low 3-year percentile range.
Institutional Buying
The latest institutional holdings are 188.32M shares, increasing 0.50% quarter-over-quarter.
Held by Manning & Napier Group, LLC
Star Investor Manning & Napier Group, LLC holds 95.28K shares of this stock.